PlainRecalls
FDA Drug Moderate Class II Terminated

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

Reported: January 29, 2020 Initiated: January 10, 2020 #D-0799-2020

Product Description

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

Reason for Recall

Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).

Details

Units Affected
4295 Kits
Distribution
Nationwide in the US and Canada
Location
Millburn, NJ

Frequently Asked Questions

What product was recalled?
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.. Recalled by Advanced Accelerator Applications USA, Inc.. Units affected: 4295 Kits.
Why was this product recalled?
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Which agency issued this recall?
This recall was issued by the FDA Drug on January 29, 2020. Severity: Moderate. Recall number: D-0799-2020.